Ian T. Magrath DSc (Med), FRCP, FRCPath
President, International Network for Cancer Treatment and Research,
Adjunct Professor of Pediatrics, Uniformed Services University of the Health Sciences,
International Network for Cancer Treatment and Research,
Brussels, Belgium
Section editors:
Kishor Bhatia PhD, FRCPath
Director, AIDS Malignancy Program
OHAM, NCI, NIH
Bethesda, MD
USA
Paolo Boffetta MD, MPH
Head of Environment Section, IARC
Lifestyle and Cancer Group
International Agency for Research on Cancer
Lyon
France
Claire Dearden BSc, MD, FRCP, FRCPath
Consultant Haematologist
Department of Haemato-Oncology
Royal Marsden NHS Foundation Trust and Institute of Cancer Research
London
UK
Volker Diehl MD, PhD
Professor of Internal Medicine, Hematology and Oncology
Honorary Chairman of German Hodgkin Study Group (GHSG)
Former Head of Department I of Internal Medicine
University Hospital Cologne
Cologne
Germany
Randy D. Gascoyne MD, FRCPC
Clinical Professor of Pathology
Department of Pathology and Laboratory Medicine
British Columbia Cancer Agency and
The University of British Columbia
Research Director, Centre for Lymphoid Cancers
Senior Scientist, BC Cancer Research Centre
Vancouver, BC
Canada
Hans Konrad Ma ller-Hermelink Prof. Dr. Dr. h. c.
Professor and Chairman
Institute of Pathology
University of Wa rzburg
Wa rzburg
Germany
Michael Potter MD
Scientist, Emeritus
Laboratory of Cell Biology and Genetics
National Cancer Institute, NIH
Bethesda, MD
USA
Ama Z. S. Rohatiner MD, FRCP
Professor of Haemato-Oncology
Department of Medical Oncology,
St. Bartholomew's Hospital
London
UK